Biotech

All Articles

Eli Lilly leaps deeper right into AI with $409M Hereditary Surge package

.Eli Lilly has vaulted right into an AI-enabled drug finding deal, partnering with RNA professional ...

After FDA being rejected and layoffs, Lykos chief executive officer is actually leaving behind

.Lykos CEO and owner Amy Emerson is leaving, with main running policeman Michael Mullette consuming ...

Novartis ignites brand new stage of Voyager pact along with $15M capsid deal

.Novartis is opening a brand new frontier in its own partnership with Voyager Therapies, spending $1...

Lilly blog posts extra favorable information on its own regular the hormone insulin prospect

.On the heels of an FDA denial for its own chief rival Novo Nordisk, Eli Lilly is pushing on in the ...

IN 8bio stops phase 2 trial, lays off one-half of staff

.Only a couple of months after application the 1st person in a stage 2 test for freshly detected gli...

Lilly, Haya ink $1B biobuck obesity deal to explore dark genome

.Eli Lilly's hunt for excessive weight intendeds has led it to the darker genome. The Big Pharma has...

ArsenalBio raises $325M, rotates far from former lead asset

.Arsenal Biosciences is actually moving on up. The tissue treatment business has added on $325 milli...

Lilly- supported effective weight loss biotech files IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis usage medication fails period 2b, steering Indivior to reconsider $100M possibility

.Aelis Farma's hopes of safeguarding a quick, beneficial selection on a $one hundred million option ...

ProKidney halts phase 3 trial not needed to have for tissue treatment permission

.ProKidney has actually stopped among a set of phase 3 tests for its own cell treatment for kidney i...